J

Jacobson Pharma Corporation Ltd
HKEX:2633

Watchlist Manager
Jacobson Pharma Corporation Ltd
HKEX:2633
Watchlist
Price: 1.25 HKD Market Closed
Market Cap: HK$2.5B

Net Margin

19.7%
Current
Improving
by 1%
vs 3-y average of 18.7%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
19.7%
=
Net Income
HK$302.6m
/
Revenue
HK$1.5B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
19.7%
=
Net Income
HK$302.6m
/
Revenue
HK$1.5B

Peer Comparison

Country Company Market Cap Net
Margin
HK
Jacobson Pharma Corporation Ltd
HKEX:2633
2.5B HKD
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
538.2B USD
Loading...
CH
Roche Holding AG
SIX:ROG
279.1B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
214.8B GBP
Loading...
CH
Novartis AG
SIX:NOVN
223.2B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
267.5B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
149.5B USD
Loading...
FR
Sanofi SA
PAR:SAN
97.4B EUR
Loading...

Market Distribution

Higher than 88% of companies in Hong Kong
Percentile
88th
Based on 3 006 companies
88th percentile
19.7%
Low
-239 513 300% — -12.9%
Typical Range
-12.9% — 5.3%
High
5.3% — 203 056%
Distribution Statistics
Hong Kong
Min -239 513 300%
30th Percentile -12.9%
Median 0.5%
70th Percentile 5.3%
Max 203 056%

Jacobson Pharma Corporation Ltd
Glance View

Market Cap
2.5B HKD
Industry
Pharmaceuticals

Jacobson Pharma Corp. Ltd. engages in the provision of generic drugs for both public and private sectors. The company employs 1,723 full-time employees The company went IPO on 2016-09-21. The firm runs its business via two segments. Generic Drugs segment develops, manufactures and distributes a host of off-patent medicine for various therapeutic uses. Currently the activities in this regard are primarily carried out in Hong Kong. Proprietary Chinese Medicines segment develops, manufactures and distributes Chinese medicines. Currently the activities in this regard are primarily carried out in Hong Kong.

Intrinsic Value
2.22 HKD
Undervaluation 44%
Intrinsic Value
Price
J
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
19.7%
=
Net Income
HK$302.6m
/
Revenue
HK$1.5B
What is Jacobson Pharma Corporation Ltd's current Net Margin?

The current Net Margin for Jacobson Pharma Corporation Ltd is 19.7%, which is above its 3-year median of 18.7%.

How has Net Margin changed over time?

Over the last 3 years, Jacobson Pharma Corporation Ltd’s Net Margin has increased from 12.6% to 19.7%. During this period, it reached a low of 12.6% on Sep 30, 2022 and a high of 19.8% on Mar 31, 2023.

Back to Top